AR056558A1 - Metodos para estabilizar composiciones oftalmicas - Google Patents

Metodos para estabilizar composiciones oftalmicas

Info

Publication number
AR056558A1
AR056558A1 ARP060104337A ARP060104337A AR056558A1 AR 056558 A1 AR056558 A1 AR 056558A1 AR P060104337 A ARP060104337 A AR P060104337A AR P060104337 A ARP060104337 A AR P060104337A AR 056558 A1 AR056558 A1 AR 056558A1
Authority
AR
Argentina
Prior art keywords
stabilize
ophthalm
compositions
methods
ophthalmic
Prior art date
Application number
ARP060104337A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR056558A1 publication Critical patent/AR056558A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un método que comprende la estabilizacion, durante la permanencia en autoclave, de un compuesto oftálmico oxidativamente inestable disuelto en una solucion oftálmica mediante la incorporacion de una cantidad efectiva para la estabilizacion de por lo menos un polímero rico en electrones a dicha solucion oftálmica Reivindicacion 13: Una solulcion apta para ser sometida a autoclave que comprende una solucion oftálmica que comprende por lo menos un compuesto oftálmico oxidativamente inestable y una cantidad efectiva para estabilizar de por lo menos un polímero rico en electrones.
ARP060104337A 2005-09-30 2006-10-02 Metodos para estabilizar composiciones oftalmicas AR056558A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/240,930 US20070077302A1 (en) 2005-09-30 2005-09-30 Methods for stabilizing ophthalmic compositions

Publications (1)

Publication Number Publication Date
AR056558A1 true AR056558A1 (es) 2007-10-10

Family

ID=37561295

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104337A AR056558A1 (es) 2005-09-30 2006-10-02 Metodos para estabilizar composiciones oftalmicas

Country Status (11)

Country Link
US (1) US20070077302A1 (es)
EP (1) EP1774961A3 (es)
JP (1) JP2007099769A (es)
KR (1) KR20070037402A (es)
CN (1) CN1939277A (es)
AR (1) AR056558A1 (es)
AU (1) AU2006225171B2 (es)
BR (1) BRPI0605508A (es)
CA (1) CA2561694A1 (es)
SG (1) SG131102A1 (es)
TW (2) TWI427052B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA94938C2 (ru) * 2006-03-31 2011-06-25 ВИСТЕКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты)
ES2594655T3 (es) * 2006-03-31 2016-12-21 Vistakon Pharmaceuticals, Llc Tratamiento de alergias oculares
AU2013201367B2 (en) * 2006-03-31 2014-07-17 Johnson & Johnson Vision Care, Inc. Ocular allergy treatments
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
TWI412381B (zh) * 2009-03-23 2013-10-21 Far Eastern New Century Corp Contact lens cleaning and maintenance liquid
CN115444849A (zh) * 2016-08-23 2022-12-09 大塚制药株式会社 具有改善的防腐效力或光稳定性的眼科药物组合物
US11253625B2 (en) * 2018-06-27 2022-02-22 Bausch & Lomb Incorporated Ophthalmic device packaging solutions comprising a poloxamine/erythritol mixture
CN112807275B (zh) * 2019-11-15 2022-05-20 湖北远大天天明制药有限公司 一种眼用组合物及其制备方法与应用
CN111450051B (zh) * 2020-04-21 2022-03-18 武汉贝参药业股份有限公司 一种富马酸酮替芬口服溶液的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2422904A1 (de) * 1974-05-11 1975-11-20 Hoechst Ag Niedermolekulares poly-n-vinyl-nmethyl-acetamid fuer die anwendung in arzneimittelzubereitungen
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
JPH0725750A (ja) * 1993-05-20 1995-01-27 Medproject Pharma Entwickl & Vertriebs Gmbh 眼科用ゲル
EP0920338A2 (en) * 1996-08-12 1999-06-09 MedLogic Global Corporation Composition for pharmaceutical applications
JPH10139666A (ja) * 1996-11-15 1998-05-26 Sawai Seiyaku Kk 液剤およびその製造方法
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
HU226588B1 (en) * 1998-04-02 2009-04-28 Novartis Ag Method for stabilizing pharmaceutical compositions by special use an antioxidant
AU7936198A (en) * 1998-07-01 2000-01-24 Lead Chemical Co., Ltd. Ketotifen preparation for percutaneous absorption
US6444710B1 (en) * 1998-10-27 2002-09-03 Alcon Manufacturing, Ltd. Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
US6777429B1 (en) * 1999-07-23 2004-08-17 Novartis Ag Ophthalmic composition
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
AU2002345015A1 (en) * 2001-06-08 2002-12-23 Novartis Pharma Gmbh Ophthalmic once-a-day composition
AR034371A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
EP1412014A4 (en) * 2001-06-14 2005-06-15 Cook Inc ENDOVASCULAR FILTER
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US6743439B1 (en) * 2001-06-27 2004-06-01 Alcon, Inc. Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine

Also Published As

Publication number Publication date
TW200728247A (en) 2007-08-01
SG131102A1 (en) 2007-04-26
TWI435735B (zh) 2014-05-01
TW201247243A (en) 2012-12-01
TWI427052B (zh) 2014-02-21
AU2006225171B2 (en) 2012-04-26
EP1774961A3 (en) 2007-09-05
EP1774961A2 (en) 2007-04-18
KR20070037402A (ko) 2007-04-04
US20070077302A1 (en) 2007-04-05
BRPI0605508A (pt) 2007-09-04
CA2561694A1 (en) 2007-03-30
AU2006225171A1 (en) 2007-04-19
CN1939277A (zh) 2007-04-04
JP2007099769A (ja) 2007-04-19

Similar Documents

Publication Publication Date Title
AR056558A1 (es) Metodos para estabilizar composiciones oftalmicas
CY1119269T1 (el) Θεραπεια βλαβων που προκαλουνται απο ιους
AR055095A1 (es) Nuevos inhibidores macrociclicos de la replicacion del virus de la hepatitis c
CO6341526A2 (es) Povidona yodada, un preservativo alternativo novedoso para composiciones oftalmologicas
AR061887A1 (es) Una composicion de vacuna contra el dengue
ECSP099780A (es) Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c
CY1113449T1 (el) Αντι-ιικες συνθεσεις που περιλαμβανουν γερανιολη και καρβονη
NI201000053A (es) Trans-clomifeno para el síndrome metabólico.
ECSP066959A (es) Compuestos macrociclicos como inhibidores de la replicación viral
CR20110043A (es) Mezclas fungicidas que comprenden 1-metilpirazol-4-ilcarboxanilidas sustituidas
ECSP10010612A (es) Nuevos inhibidores macrociclicos de la replicacion del virus de la hepatitis c
CO6511251A2 (es) Compuestos quimicos
UY29526A1 (es) Amidas de rcido pirazolcarboxelico
ECSP066891A (es) Mezclas fungicidas
AR080495A1 (es) Composicion para el blanqueamiento de los dientes. metodo.
CR9392A (es) O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
CU20090112A6 (es) Compuestos macrocíclicos como inhibidores de la replicación viral
CR10943A (es) Mezclas fungicidas a partir de 1-metilpirazol- 4- ilcarboxanilidas y azolopirimidinilaminas
ES2571730T3 (es) Composiciones farmacéuticas que comprenden droxidopa
UY31051A1 (es) Mezclas fungicidas
UY31780A (es) Fenoxibenzamidas sustituidas
CR20110190A (es) Agente rodenticida sinérgico
RU2013110517A (ru) Средство для профилактики или лечения неалкогольного стеатогепатита
NI200700218A (es) Derivados de amida como ligandos de canales iónicos y composiciones farmacéuticas y métodos para usar los mismos.
AR078167A1 (es) Dispersion solida que comprende un agente anti-vih

Legal Events

Date Code Title Description
FA Abandonment or withdrawal